Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.
about
Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and PreventionAdvances in alloimmune thrombocytopenia: perspectives on current concepts of human platelet antigens, antibody detection strategies, and genotypingFc receptors in immune thrombocytopenias: a target for immunomodulation?Recombinant HPA-1a antibody therapy for treatment of fetomaternal alloimmune thrombocytopenia: proof of principle in human volunteersPlatelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopeniaLow-affinity FcγR interactions can decide the fate of novel human IgG-sensitised red blood cells and platelets.
P2860
Developing recombinant HPA-1a-specific antibodies with abrogated Fcgamma receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Developing recombinant HPA-1a- ...... l alloimmune thrombocytopenia.
@ast
Developing recombinant HPA-1a- ...... l alloimmune thrombocytopenia.
@en
type
label
Developing recombinant HPA-1a- ...... l alloimmune thrombocytopenia.
@ast
Developing recombinant HPA-1a- ...... l alloimmune thrombocytopenia.
@en
prefLabel
Developing recombinant HPA-1a- ...... l alloimmune thrombocytopenia.
@ast
Developing recombinant HPA-1a- ...... l alloimmune thrombocytopenia.
@en
P2093
P2860
P356
P1476
Developing recombinant HPA-1a- ...... l alloimmune thrombocytopenia.
@en
P2093
Cedric Ghevaert
David A Wilcox
Kathryn L Armour
Lorna M Williamson
P2860
P304
P356
10.1172/JCI34708
P407
P577
2008-08-01T00:00:00Z